|Publication number||WO1995033986 A1|
|Publication date||14 Dec 1995|
|Filing date||5 Jun 1995|
|Priority date||6 Jun 1994|
|Also published as||CA2192196A1, CA2192196C, EP0764266A1, EP0764266A4|
|Publication number||PCT/1995/7145, PCT/US/1995/007145, PCT/US/1995/07145, PCT/US/95/007145, PCT/US/95/07145, PCT/US1995/007145, PCT/US1995/07145, PCT/US1995007145, PCT/US199507145, PCT/US95/007145, PCT/US95/07145, PCT/US95007145, PCT/US9507145, WO 1995/033986 A1, WO 1995033986 A1, WO 1995033986A1, WO 9533986 A1, WO 9533986A1, WO-A1-1995033986, WO-A1-9533986, WO1995/033986A1, WO1995033986 A1, WO1995033986A1, WO9533986 A1, WO9533986A1|
|Inventors||Anne R. Kopf-Sill, Carol T. Schembri|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (4), Non-Patent Citations (1), Referenced by (71), Classifications (5), Legal Events (8)|
|External Links: Patentscope, Espacenet|
MODIFIED SIPHONS FOR IMPROVED METERING PRECISION
The present application is a continuation in part of copending application U.S.S.N. 08/115,162, which i incorporated herein by reference.
BACKGROUND OF THE INVENTION The present invention relates generally to devices and methods for analyzing biological fluids. In particular, it relates to the design and use of improved centrifugal rotors having siphons which allow delivery of a precise volume of liquid to a chamber in the rotor. Biological tests of blood plasma and other biological fluids frequently require that fluids be quickly divided into predetermined volumes for analysis in a variety of optical tests or assays. It is also frequently desirable to separate potentially interfering cellular components of the material from the other fluid prior to testing. Such measurement and separation steps have previously been typically performed by centrifugation to separate, for instance, blood plasma from the cellular components, followed by manual or automated pipetting of predetermined volumes of the blood plasma into separate test wells. Such procedures are labor intensive and time-consuming. As a result, various automated systems and methods have been proposed for providing multiple aliquots of plasma suitable for testing in a more efficient manner. A major advance in the analysis of biological fluids has been the use of centrifugal rotors. These rotors are designed to measure volumes of a biological fluid, such as blood, remove cellular components, and mix the fluid with an appropriate diluent for analysis, for example by optical testing. Typically, the rotors provide a plurality of discrete volumes of sample in separate cuvettes in which the sample is optically analyzed. To ensure accurate and consistent results, such rotors require the delivery of precisely measured volumes of liquid to various chambers in the rotor. This must often be accomplished in circumstances in which the rotor quickly accelerates and decelerates or is otherwise perturbed during operation. This perturbation can often lead to delivery of inaccurately measured volumes. The present invention addresses these and other needs. Description of the Background Art U.S. Patent Nos. 4,894,204, and 5,160,702 disclose siphons for transferring fluids between chambers in a rotor. U.S. Patent No. 4,244,916 discloses a rotor comprising a plurality of cuvettes positioned radially outward of a central receptacle. Each cuvette is connected to the central receptacle by a duct and comprises a separate air escape orifice. U.S. Patent No. 4,314,968 relates to rotors having cells positioned on the periphery of the rotor. Each cell includes a peripheral orifice for removing fluid introduced into the cell. U.S. Patent No. 4,902,479 discloses a multi- cuvette rotor comprising elongated, radially extending cuvettes. Each elongated cuvette comprises a first chamber for receiving a first constituent and a second chamber for receiving a second constituent. A divider structure between the first and second chambers prevents mixing of the constituents before a predetermined time. Mixing occurs as the rotor is spun at a sufficient speed. U.S. Patent No. 4,963,498 discloses devices which rely upon capillaries, chambers, and orifices to pump and mix fluids for optical analysis. U.S. Patent No. 5,077,013 discloses rotors comprising peripheral cuvettes connected to holding chambers positioned radially inward from the cuvettes.
SUMMARY OF THE INVENTION The present invention provides centrifugal rotors comprising siphons for delivering a premeasured volume of liquid, typically a biological sample such as plasma, between a first and a second chamber in the rotor. The siphons of the invention have an elbow that is radially inward of the radially most inward point of the fluid in the first chamber. As the rotor is spinning the fluid does not flow past the elbow. After the rotor stops, capillary forces "prime" the siphon by pulling fluid just around the elbow. When the rotor is restarted, centrifugal force draws the remaining fluid out of the metering chamber into the receiving chamber until the level of the fluid in the metering chamber is at the same radial distance as the outlet of the siphon. The siphons of the invention are designed such that the inlet of the siphon on the first chamber is radially outward of the siphon outlet on the second chamber.
The positioning of the inlets and outlets of the siphons of the invention provide a number of advantages. For example, the inlet of the siphon is always positioned radially outward of the final position of the meniscus of the fluid in the first chamber, after fluid has been transferred to the second chamber. Thus, inaccuracy in measurement associated with different shaped menisci in different fluids is minimized since the meniscus is minimized. In addition, one of skill will recognize that all siphons are semi-stable because the train of fluid in a siphon is stable but easily broken if the rotor is perturbed. When the train of fluid is broken, under centrifugal force, the fluid contained in the siphon will flow to the radially most outward point. In prior art siphons this point is the siphon outlet. Thus, the potential exists for the delivery of unmetered volumes of fluid to the receiving chamber. In the siphons of the present invention, the radially most outward point in the siphon is the siphon inlet. In this design, the problem of delivering unmetered volumes of fluid is avoided because the fluid flows back into the first chamber when the train of fluid is broken.
The chambers connected by the siphons of the invention are used to perform any of a number of functions, such as metering liquids, separating solid components from a sample, mixing diluent with the sample, and the like. In the preferred embodiments, the siphons connect a plasma metering chamber to a mixing chamber for mixing the premeasured volume of plasma with diluent. In addition, the rotors of the invention comprise unmodified inlet channels connecting a distribution ring to cuvettes comprising reagents for optical analysis of a biological sample. The inlet channels are sized such that, as the rotor spins, gas escapes from the cuvette through the inlet channel as the liquid enters the cuvette through the inlet channel. An "unmodified inlet channel" as used herein refers to a simple inlet channel, typically having a rectangular cross section, which is not modified (e.g., by altering the cross-sectional shape, surface texture, and the like) to provide a pathway for gas to escape from a cuvette that is not otherwise vented.
BRIEF DESCRIPTION OF THE DRAWINGS Figs. 1A-1F are top plan views of a rotor of the invention showing the flow of fluids through the chambers and channels of the rotor as the rotor is spun.
DESCRIPTION OF THE PREFERRED EMBODIMENT The present invention provides methods and devices for the delivery of liquids to chambers in an analytical rotor. The rotors of the invention comprise siphons which ensure precise delivery of etered volumes of liquid to a desired chamber in the rotor.
The rotors of the invention are suitable for the analysis of any liquid, typically a biological sample such as whole blood or plasma. It is also useful with numerous other biological fluids, such as urine, sputum, semen, saliva, ocular lens fluid, cerebral fluid, spinal fluid, amniotic fluid. Other fluids that can be tested include tissue culture media, food and industrial chemicals, environmental samples and the like.
The rotors typically provide chambers which can separate cellular components from the biological sample (e.g. whole blood) , measure a precise volume of liquid sample (e.g. plasma) , mix the sample with an appropriate diluent and deliver the diluted sample to cuvettes for optical analysis. The fluid delivered to the cuvettes, undergoes reaction(s) within the cuvettes, e.g., reaction with a reagent which forms part of an analytical procedure to detect one or more analytes within the fluid. The sample may further be optically analyzed while present in the rotor, either with or without prior reaction. The apparatus of the present invention comprises an analytical rotor having a rotor body which is capable of being mounted on a conventional laboratory centrifuge of the type which is commercially available from suppliers, such a Beckman Instruments, Inc., Spinco Division, Fullerton, California; Fisher Scientific, Pittsburgh, Pennsylvania; VWR Scientific, San Francisco, California, and the like. Generally, the centrifugal rotor will include a receptacle or other coupling device suitable for mounting on a vertical drive shaft provided by the centrifuge. The particular design of the receptacle or coupling device will depend on the nature of the centrifuge, and it will be appreciated that the centrifugal rotor of the present invention may be adapted for use with all or most types of centrifuges which are now available or which may become available in the future. The rotor body comprises a structure which maintains a desired geometric pattern or relationship between a plurality of chambers, interconnecting passages, and vents, as described in more detail below. Various specialized chambers and channels suitable for use in the rotors of the invention are disclosed in U.S. Patent Nos. 5,061,381 and 5,122,284, and U.S.S.N. 07/678,762 and 07/783,041 which are incorporated herein by reference.
Usually, the body will be a substantially solid plate or disk with the chambers and passages formed as spaces or voids in the otherwise solid matrix. Conveniently, such solid plate structures may be formed by laminating a plurality of separately-formed layers together into a composite structure where the chambers and horizontal passages are generally formed between adjacent layers. The vertical passages may be formed through the layers. The individual layers may be formed by injection molding, machining, or combinations thereof, and will usually be joined together, typically using a suitable adhesive or by ultrasonic welding. The final enclosed volumes are formed when the layers are brought together.
Of course, the centrifugal rotor could also be formed as a plurality of discrete components, such as tubes, vessels, chambers, etc., arranged in a suitable framework.
Such assemblies of discrete components, however, are generally more difficult to manufacture and are therefore less desirable than those formed within a substantially solid plate.
The rotor body may be formed from a wide variety of materials and may optionally include two or more materials. Usually, the material(s) will be transparent so that the presence and distribution of the biological fluid, cellular components, and reagents, may be observed within the various internal chambers and passages. Optionally, to the extent analytical chambers, e.g., cuvettes, or other test wells are formed within the rotor, it is desirable to have suitable optical paths formed within the rotor so that the contents of the cuvettes may be observed spectrophotometrically, fluorometrically, or by other optical assessment instruments. The construction of suitable cuvettes having particular optical paths formed therethrough is disclosed in U.S. Patent No. 5,173,193, the disclosure of which is incorporated herein by reference. In the preferred embodiment, the rotor is formed with an acrylic resin having suitable optical properties, at least in those areas which define an optical path.
The apparatus and method of the present invention are suitable for performing a wide variety of analytic procedures and assays which are beneficially or necessarily performed on blood plasma and other samples. The analytic procedures may require that the sample be combined with one or more reagents so that some detectable change occurs which may be related to the presence and/or amount of a particular component (analyte) or characteristic of the sample. For instance, the sample may undergo a reaction or other change which results in a change in color, fluorescence, luminescence, or the like, which may be measured by conventional spectrophotometers, fluorometers, light detectors, and the like. In some cases, immunoassays and other specific binding assays may be performed within the cell-free fluid collection chamber or within cuvettes which are connected to the collection chamber. Generally, such assay procedures should be homogeneous and not require a separation step. In other cases, however, it may be possible to accommodate heterogeneous assay systems by providing a means to separate the sample (e.g., blood plasma) from the collection chamber or another test well or cuvette after the immunological reaction step has occurred. One of skill will recognize that the means of analyzing the sample is not an important aspect of the invention. Any of a number of analytical methods can be adapted for use in the rotors of the invention, depending upon the particular sample being analyzed and component being detected.
In the case of blood analyses, conventional blood assays are typically preformed. Examples of assays which may be performed include those designed to detect glucose, lactate dehydrogenase, serum glutamic-oxaloacetic transaminase (SGOT) , serum glutamic-pyruvic transaminase (SGPT) , blood urea nitrogen (BUN) , total protein, alkalinity, phosphatase, bilirubin, calcium, chloride, sodium, potassium, magnesium, and the like. This list is not exhaustive and is intended merely as being exemplary of the assays which may be performed using the apparatus and method of the present invention.
Usually, these tests will require that the blood and plasma be combined with one or more reagents which result in an optically detectable, usually photometrically detectable, change in the plasma. The reagents which are required are well known and amply described in the patent and scientific literature.
The reagents are preferably provided in lyophilized form to increase stability. Ideally, they are provided in the form of lyophilized reagent spheres as described in U.S.S.N. 07/747,179, which is incorporated herein by reference.
Referring now to Figures 1A-F, an analytical rotor comprising the chambers and channels of the present invention can be seen. Figure 1A shows the position of a blood sample 102 in the blood application chamber 104 after the sample has been loaded in the rotor body 100. A diluent container in chamber 106 is opened upon mounting of the rotor on the spindle of the centrifuge as described in copending and commonly assigned application, U.S. Serial No. 07/873,327, which is incorporated herein by reference.
Fig. IB shows the position of the diluent 108 and blood sample 102 after the rotor is spun at 4,000 rpm. The blood sample 102 begins to exit the blood application chamber 104 and enters the plasma metering chamber 110. At the same time, diluent 108 empties from the diluent container into the holding chamber 112. The diluent immediately begins to enter the diluent metering chamber 114 through channel 116.
Fig. 1C shows the position of the liquids as the rotor 100 continues to spin. Here, the blood sample 102 has emptied the blood application chamber 104 and overflows the plasma metering chamber 110 into the overflow chamber 118 where it flows to the hemoglobin cuvette 120 and the excess blood dump 122. Meanwhile, diluent 108 fills the diluent metering chamber 114 and excess flows through channel 124 to diluent-only cuvettes 126 and excess diluent dump 127.
Fig. ID shows the position of the liquids at the conclusion of the first spin. The blood sample 102 has separated into cells 128 and plasma 130. The diluent-only cuvettes 126 are filled and a predetermined amount of diluent remains in the diluent metering chamber 114. The rotor 100 is then stopped and the siphon 132 from the diluent metering chamber 114, as well as the siphon 134 from the plasma metering chamber 110, are allowed to prime, as described above. Siphon 134 is a siphon of the present invention. It is connected to the plasma metering chamber 110 at inlet 138. The inlet 138 is position radially outward of the siphon outlet 139, through which the siphon 134 empties into the mixing chamber 136. Fig. IE shows the position of the liquids during the second spin of the rotor. The diluent metering chamber 114 empties into the mixing chamber 136 through siphon 132. A predetermined amount of plasma 130 is metered into the mixing chamber 136 and the two fluids are mixed, thereby forming diluted plasma 131. The amount of plasma 130 delivered to the mixing chamber 136 is determined by the position of the outlet 139 on the siphon 134. As can be seen in this figure, the final level of the plasma 133 in the plasma metering chamber 110 is at the same radial position as the outlet 139. Thus, the volume of plasma delievered to the mixing chamber 136 is determined by the volume of the plasma metering chamber 110 between the exit to the overflow chamber 129 and the final level of plasma 133. After the plasma and diluent are mixed in the mixing chamber 136, the rotor is stopped again and the output siphon 140 is primed.
Fig. IF shows the position of the diluted plasma 131 as the rotor is spun during the third spin. This figure illustrates the movement of the diluted plasma 131 through the distribution ring 142 and inlet channels 144 to the cuvettes 146 and excess plasma dump 147. The resistance to flow in the output siphon 140 is selected to be higher than the resistance to flow in the distribution ring 142 and the inlet channels 144 so that air present in the cuvettes 146 can escape as the cuvettes are filled. Specifically, siphon 140 is dimensioned such that the ratio of the cross sectional area of the inlet channels 144 to the cross sectional area of the liquid in them is greater than 2:1, preferably greater than about 4:1. The cross sectional area of the inlet channels 144 is typically the same as or slightly smaller than that of the distribution channel 142 so that gas in the unvented cuvettes escapes through the inlet channels 144 and distribution 142. If the sample is plasma or diluted plasma and the channels are rectangular in cross-section, their dimensions are typically as follows: siphon: 0.150 mm depth, 0.200 mm width; distribution channel 0.300 mm depth, 0.500mm width; inlet channels: 0.150 depth, 0.500 width.
After the cuvettes have been filled, reagents present in the cuvettes are mixed with the solution and the necessary photometric analyses are made on the sample. Such analyses are carried out as described above according to methods known to those of skill in the art. Although the foregoing invention has been described in detail for purposes of clarity of understanding, it will be obvious that certain modifications may be practiced within the scope of the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4743558 *||22 Oct 1985||10 May 1988||Jean Guigan||Method of performing medical analysis on a sample of liquid by means of at least one liquid reagent, and apparatus for performing the method|
|US4894204 *||9 Dec 1988||16 Jan 1990||Inovelf||Rotor with dynamic pipeting for a centrifuge analysis device|
|US4999304 *||28 Dec 1987||12 Mar 1991||Miles Inc.||Dynamic braking centrifuge|
|US5256376 *||12 Sep 1991||26 Oct 1993||Medical Laboratory Automation, Inc.||Agglutination detection apparatus|
|1||*||See also references of EP0764266A4|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|WO2002043866A2 *||30 Nov 2001||6 Jun 2002||Burstein Technologies, Inc.||Apparatus and methods for separating components of particulate suspension|
|WO2002043866A3 *||30 Nov 2001||6 Mar 2003||Burstein Technologies Inc||Apparatus and methods for separating components of particulate suspension|
|WO2010077159A1 *||30 Dec 2009||8 Jul 2010||Biosurfit, S.A.||Analytical rotors and methods for analysis of biological fluids|
|WO2012055707A1||13 Oct 2011||3 May 2012||F. Hoffmann-La Roche Ag||Microfluidic test carrier for dividing a liquid quantity into subquantities|
|WO2012055861A1||25 Oct 2011||3 May 2012||Roche Diagnostics Gmbh||Microfluidic element for analysis of a sample liquid|
|WO2012158990A1 *||18 May 2012||22 Nov 2012||3M Innovative Properties Company||Systems and methods for volumetric metering on a sample processing device|
|CN100549696C||16 Dec 2002||14 Oct 2009||爱科来株式会社||Sample measuring device|
|CN103547370A *||18 May 2012||29 Jan 2014||3M创新有限公司||Systems and methods for volumetric metering on a sample processing device|
|DE102005048233A1 *||7 Oct 2005||12 Apr 2007||Albert-Ludwigs-Universität Freiburg||Vorrichtung und Verfahren zum Handhaben einer flüssigen Probe unter Verwendung einer Siphon-Struktur|
|DE102005048260A1 *||7 Oct 2005||12 Apr 2007||Albert-Ludwigs-Universität Freiburg||Verfahren und Vorrichtung zum Handhaben einer flüssigen Probe unter Verwendung einer Rotation mit einem zeitlich veränderlichen Drehvektor|
|EP1503209A1 *||8 May 2002||2 Feb 2005||Hitachi High-Technologies Corporation||Chemical analyzer and gene diagnosing apparatus|
|EP1503209A4 *||8 May 2002||6 Jul 2005||Hitachi High Tech Corp||Chemical analyzer and gene diagnosing apparatus|
|EP1600778A1 *||18 Feb 2004||30 Nov 2005||Japan Science and Technology Agency||Blood analysis device and blood analysis method|
|EP1600778A4 *||18 Feb 2004||8 Aug 2012||Japan Science & Tech Agency||Blood analysis device and blood analysis method|
|EP1985366A3 *||24 Apr 2008||22 Apr 2009||Samsung Electronics Co., Ltd.||Centrifugal microfluidic device having sample distribution structure and centrifugal microfluidic system including the centrifugal microfluidic device|
|EP2072131A1 *||13 Dec 2007||24 Jun 2009||Boehringer Mannheim Gmbh||Microfluid element for mixing a fluid into a reagent|
|EP2126119A1 *||29 Feb 2008||2 Dec 2009||Corbett Research Pty Ltd||Apparatus and method for nucleic acid amplification|
|EP2126119A4 *||29 Feb 2008||16 Jul 2014||Corbett Res Pty Ltd||Apparatus and method for nucleic acid amplification|
|EP2269736A1||28 Aug 2002||5 Jan 2011||Gyros Patent Ab||Retaining microfluidic microcavity and other microfluidic structures|
|EP2281633A1||28 Aug 2002||9 Feb 2011||Gyros Patent Ab||Retaining microfluidic microcavity and other microfluidic structures|
|EP2283924A1||28 Aug 2002||16 Feb 2011||Gyros Patent Ab||Retaining microfluidic microcavity and other microfluidic structures|
|EP2420319A1 *||24 Apr 2008||22 Feb 2012||Samsung Electronics Co., Ltd||Centrifugal microfluidic device having sample distribution structure and centrifugal microfluidic system including the centrifugal microfluidic device|
|EP2455162A1||29 Oct 2010||23 May 2012||Roche Diagnostics GmbH||Microfluidic element for analysing a fluid sample|
|EP2486978A1||28 Oct 2010||15 Aug 2012||Roche Diagnostics GmbH||Microfluid test carrier for separating a fluid volume in partial volumes|
|US5627041 *||2 Sep 1994||6 May 1997||Biometric Imaging, Inc.||Disposable cartridge for an assay of a biological sample|
|US6143247 *||19 Dec 1997||7 Nov 2000||Gamera Bioscience Inc.||Affinity binding-based system for detecting particulates in a fluid|
|US6143248 *||12 Aug 1997||7 Nov 2000||Gamera Bioscience Corp.||Capillary microvalve|
|US6302134||15 Mar 2000||16 Oct 2001||Tecan Boston||Device and method for using centripetal acceleration to device fluid movement on a microfluidics system|
|US6319468||12 Jul 2000||20 Nov 2001||Tecan Trading Ag||Affinity binding-based system for detecting particulates in a fluid|
|US6399361||21 Dec 2000||4 Jun 2002||Tecan Trading Ag||Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system|
|US6548788||16 Oct 2001||15 Apr 2003||Tecan Trading Ag||Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system|
|US6632399||19 May 1999||14 Oct 2003||Tecan Trading Ag||Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system for performing biological fluid assays|
|US6656430||20 Nov 2001||2 Dec 2003||Tecan Trading Ag||Affinity binding-based system for detecting particulates in a fluid|
|US6709869||20 Nov 2001||23 Mar 2004||Tecan Trading Ag||Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system|
|US6808633||23 Jun 1999||26 Oct 2004||Hitachi, Ltd.||Centrifugal separator and sample preparation device using the separator|
|US6919058||28 Aug 2002||19 Jul 2005||Gyros Ab||Retaining microfluidic microcavity and other microfluidic structures|
|US7033747||11 Apr 2002||25 Apr 2006||Nagaoka & Co., Ltd||Multi-parameter assays including analysis discs and methods relating thereto|
|US7054258||10 Dec 2001||30 May 2006||Nagaoka & Co., Ltd.||Optical disc assemblies for performing assays|
|US7079468||7 Dec 2001||18 Jul 2006||Burstein Technologies, Inc.||Optical discs for measuring analytes|
|US7091034||14 Dec 2001||15 Aug 2006||Burstein Technologies, Inc.||Detection system for disk-based laboratory and improved optical bio-disc including same|
|US7189368||17 Sep 2002||13 Mar 2007||Gyros Patent Ab||Functional unit enabling controlled flow in a microfluidic device|
|US7200100||30 May 2006||3 Apr 2007||Nagaoka & Co., Ltd.||Optical disc assemblies for performing assays|
|US7275858||13 Dec 2004||2 Oct 2007||Gyros Patent Ab||Retaining microfluidic microcavity and other microfluidic structures|
|US7300199||13 Dec 2004||27 Nov 2007||Gyros Ab||Retaining microfluidic microcavity and other microfluidic structures|
|US7366063||18 Jul 2006||29 Apr 2008||Burstein Technologies, Inc.||Optical discs for measuring analytes|
|US7384602||28 Mar 2003||10 Jun 2008||Hitachi High-Technologies Corporation||Chemical analysis apparatus and genetic diagnostic apparatus|
|US7390464||26 Jul 2004||24 Jun 2008||Burstein Technologies, Inc.||Fluidic circuits for sample preparation including bio-discs and methods relating thereto|
|US7429354||19 Mar 2002||30 Sep 2008||Gyros Patent Ab||Structural units that define fluidic functions|
|US7459129||13 Dec 2004||2 Dec 2008||Gyros Patent Ab||Retaining microfluidic microcavity and other microfluidic structures|
|US7542383||3 Apr 2007||2 Jun 2009||Vindur Technologies, Inc.||Optical disc assemblies for performing assays|
|US7599275||22 Apr 2008||6 Oct 2009||Vindur Technologies, Inc.||Optical discs for measuring analytes|
|US7749442||16 Dec 2002||6 Jul 2010||Arkray, Inc.||Sample measuring device|
|US7850909||25 Sep 2003||14 Dec 2010||Arkray, Inc.||Analytical tool|
|US7889615||25 Aug 2009||15 Feb 2011||Vindur Technologies, Inc.||Optical discs for measuring analytes|
|US8048387||24 Apr 2008||1 Nov 2011||Samsung Electronics Co., Ltd.||Centrifugal microfluidic device having sample distribution structure and centrifugal microfluidic system including the centrifugal microfluidic device|
|US8303908||24 Oct 2003||6 Nov 2012||Arkray, Inc.||Analyzing tool and device|
|US8440147||30 Dec 2009||14 May 2013||Biosurfit, S.A.||Analytical rotors and methods for analysis of biological fluids|
|US8596150||30 Jun 2009||3 Dec 2013||Panasonic Corporation||Analytical device with mixing cavity|
|US8865005||20 Oct 2009||21 Oct 2014||Biosurfit, S.A.||Jet deflection device|
|US8916112||26 Mar 2011||23 Dec 2014||Biosurfit, S.A.||Liquid distribution and metering|
|US8931331||18 May 2012||13 Jan 2015||3M Innovative Properties Company||Systems and methods for volumetric metering on a sample processing device|
|US9013704||7 Dec 2010||21 Apr 2015||Biosurfit, S.A.||Surface plasmon resonance detection system|
|US9046503||30 Jun 2009||2 Jun 2015||Panasonic Healthcare Co., Ltd.||Analyzing device|
|US9067205||18 May 2012||30 Jun 2015||3M Innovative Properties Company||Systems and methods for valving on a sample processing device|
|US9145579||24 Jun 2013||29 Sep 2015||Panasonic Healthcare Co., Ltd.||Analyzing device|
|US9168523||18 May 2012||27 Oct 2015||3M Innovative Properties Company||Systems and methods for detecting the presence of a selected volume of material in a sample processing device|
|US9186671||26 Apr 2013||17 Nov 2015||Roche Diagnostics Operations, Inc.||Microfluidic test carrier for apportioning a liquid quantity into subquantities|
|US9221051||29 Apr 2013||29 Dec 2015||Roche Diagnostics Operations, Inc.||Microfluidic element for analysis of a sample liquid|
|US9417164||14 Mar 2013||16 Aug 2016||Roche Diagnostics Operations, Inc.||Microfluidic element for thoroughly mixing a liquid with a reagent|
|US9562262||7 Mar 2012||7 Feb 2017||UNIVERSITé LAVAL||Fluidic centripetal device|
|US9725762||13 Oct 2015||8 Aug 2017||Diasorin S.P.A.||Systems and methods for detecting the presence of a selected volume of material in a sample processing device|
|International Classification||G01N35/00, G01N21/07, G01N33/48|
|14 Dec 1995||AK||Designated states|
Kind code of ref document: A1
Designated state(s): CA JP
|14 Dec 1995||AL||Designated countries for regional patents|
Kind code of ref document: A1
Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE
|21 Mar 1996||DFPE||Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)|
|27 Mar 1996||121||Ep: the epo has been informed by wipo that ep was designated in this application|
|5 Dec 1996||ENP||Entry into the national phase in:|
Ref country code: CA
Ref document number: 2192196
Kind code of ref document: A
Format of ref document f/p: F
|5 Dec 1996||WWE||Wipo information: entry into national phase|
Ref document number: 2192196
Country of ref document: CA
|20 Dec 1996||WWE||Wipo information: entry into national phase|
Ref document number: 1995922222
Country of ref document: EP
|26 Mar 1997||WWP||Wipo information: published in national office|
Ref document number: 1995922222
Country of ref document: EP